Pharmacokinetics of Gingerols, Shogaols, and Their Metabolites in Asthma Patients.


Journal

Journal of agricultural and food chemistry
ISSN: 1520-5118
Titre abrégé: J Agric Food Chem
Pays: United States
ID NLM: 0374755

Informations de publication

Date de publication:
10 Aug 2022
Historique:
pubmed: 3 8 2022
medline: 12 8 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

6-Gingerol and 6-shogaol are the most abundant gingerols and shogaols in ginger root and have been shown to reduce the asthmatic phenotype in murine models of asthma. Several studies have described the pharmacokinetics of gingerols and shogaols in humans following the oral ingestion of ginger, while little was known about the metabolism of these components in humans, particularly in patients with asthma. In this study, a dietary supplement of 1.0 g of ginger root extract was administered to asthma patients twice daily for 56 days and serum samples were drawn at 0.5-8 h on days 0, 28, and 56. The metabolic profiles of gingerols and shogaols in human plasma and the kinetic changes of gingerols, shogaols, and their metabolites in asthma patients collected on the three different visits were analyzed using liquid chromatography-mass spectrometry (LC-MS). Ketone reduction was the major metabolic pathway of both gingerols and shogaols. Gingerdiols were identified as the major metabolites of 6-, 8-, and 10-gingerols. M11 and M9 were identified as the double-bond reduction and both the double-bond and ketone reduction metabolites of 6-shogaol, respectively. Cysteine conjugation was another major metabolic pathway of 6-shogaol in asthma patients, and two cysteine-conjugated 6-shogaol, M1 and M2, were identified as the major metabolites of 6-shogaol. Furthermore, gingerols, shogaols, and their metabolites were quantitated in the human serum collected at different time points during each of the three visits using a very sensitive high-resolution LC-MS method. The results showed that one-third of 6-gingerol was metabolized to produce its reduction metabolites, 6-gingerdiols, and more than 90% of 6-shogaol was metabolized to its phase I and cysteine-conjugated metabolites, suggesting the importance of considering the contribution of these metabolites to the bioavailability and health beneficial effects of gingerols and shogaols. All gingerols, shogaols, and their metabolites reached their peak concentrations in less than 2 h, and their half-lives (

Identifiants

pubmed: 35916113
doi: 10.1021/acs.jafc.2c03150
pmc: PMC9654594
mid: NIHMS1846683
doi:

Substances chimiques

Catechols 0
Fatty Alcohols 0
Ketones 0
Plant Extracts 0
shogaol 83DNB5FIRF
gingerol 925QK2Z900
Cysteine K848JZ4886

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9674-9683

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL144852
Pays : United States
Organisme : NCCIH NIH HHS
ID : R61 AT009989
Pays : United States

Références

J Agric Food Chem. 2012 Nov 14;60(45):11372-7
pubmed: 23066935
Biomed Rep. 2018 Dec;9(6):474-482
pubmed: 30546874
Chem Res Toxicol. 2013 Jun 17;26(6):976-85
pubmed: 23638641
Molecules. 2019 Aug 07;24(16):
pubmed: 31394732
Molecules. 2019 Jan 31;24(3):
pubmed: 30708987
Foods. 2019 May 30;8(6):
pubmed: 31151279
Chem Res Toxicol. 2014 Sep 15;27(9):1575-85
pubmed: 25148906
J Agric Food Chem. 2013 Jun 5;61(22):5353-60
pubmed: 23701129
J Neuroimmunol. 2018 Nov 15;324:54-75
pubmed: 30243185
J Agric Food Chem. 2009 Nov 25;57(22):10645-50
pubmed: 19877681
Sci Rep. 2018 Feb 14;8(1):3056
pubmed: 29445099
Mol Nutr Food Res. 2013 May;57(5):865-76
pubmed: 23322474
Free Radic Biol Med. 2016 Jun;95:243-54
pubmed: 27021962
AAPS J. 2011 Sep;13(3):417-26
pubmed: 21638149
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Mar 15;877(8-9):671-9
pubmed: 19201263
Phytochemistry. 2015 Sep;117:554-568
pubmed: 26228533
Curr Pharm Biotechnol. 2019;20(1):5-16
pubmed: 30659535
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1930-6
pubmed: 18708382
Am J Respir Cell Mol Biol. 2014 Jan;50(1):115-24
pubmed: 23962082
Food Chem Toxicol. 2008 Feb;46(2):409-20
pubmed: 17950516
Life Sci. 2000 Oct 27;67(23):2785-93
pubmed: 11105995
Drug Metab Dispos. 2012 Apr;40(4):742-53
pubmed: 22246389
Molecules. 2017 Mar 30;22(4):
pubmed: 28358331
Complement Ther Med. 2014 Feb;22(1):9-16
pubmed: 24559810
J Agric Food Chem. 2014 May 21;62(20):4632-42
pubmed: 24786146
Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L912-L924
pubmed: 34549600
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Oct 15;907:126-39
pubmed: 23031413
Mol Nutr Food Res. 2013 Mar;57(3):447-58
pubmed: 23322393
PLoS One. 2013;8(1):e54677
pubmed: 23382939
Am J Respir Cell Mol Biol. 2013 Feb;48(2):157-63
pubmed: 23065130
Phytother Res. 2018 Oct;32(10):1885-1907
pubmed: 30009484

Auteurs

Shuwei Zhang (S)

Laboratory for Functional Foods and Human Health, Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.

Emily DiMango (E)

Department of Medicine (Pulmonology, Allergy and Critical Care), Columbia University, New York, New York 10027-6902, United States.

Yingdong Zhu (Y)

Laboratory for Functional Foods and Human Health, Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.

Tarnjot K Saroya (TK)

Department of Medicine (Pulmonology, Allergy and Critical Care), Columbia University, New York, New York 10027-6902, United States.

Charles W Emala (CW)

Department of Anesthesiology, Columbia University, New York, New York 10027-6902, United States.

Shengmin Sang (S)

Laboratory for Functional Foods and Human Health, Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH